Antibodies cover entirety of SARS-CoV-2 Spike protein, study shows 5 May 2021 | By Victoria Rees (Drug Target Review) Researchers have found that over 80 percent of antibodies target sections of the SARS-CoV-2 Spike protein other than the RBD.
New label-free imaging method created to visualise brain samples 5 May 2021 | By Victoria Rees (Drug Target Review) A novel sensitive label-free imaging method has been developed to visualise brain samples using an FxClear-based tissue clearing technique.
Global biochip market set to increase at CAGR of 12.5 percent 4 May 2021 | By Victoria Rees (Drug Target Review) According to new research, the biochip market will grow as a result of the rising demand for personalised medicine.
MIS hormone shown to suppress ovarian follicle development 4 May 2021 | By Victoria Rees (Drug Target Review) Researchers have shown how the MIS hormone can prevent ovulation in females, making it a potential new form of contraception.
New 3D lung-on-a-chip model enables study of respiratory diseases 4 May 2021 | By Victoria Rees (Drug Target Review) Scientists have developed a 3D lung-on-a-chip model of the distal lung and alveolar structures, enabling the study of COVID-19.
Small-molecule cocktail could improve use of stem cells in treatments 4 May 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that Chroman 1, Emricasan and trans-ISRIB, in combination with polyamines, are effective at protecting induced pluripotent stem cells from stress.
UK to host summit with CEPI to accelerate vaccine development 3 May 2021 | By Victoria Rees (Drug Target Review) A summit will be held between the UK and CEPI to raise funds for vaccine research and development in a bid to avert future pandemics.
New imaging method visualises respiratory activity of cell models 3 May 2021 | By Victoria Rees (Drug Target Review) Researchers have created a new imaging technique called electrochemiluminescence to visualise multiple spheroids with a single shot.
CRISPR reveals genes involved in zebrafish spinal cord regeneration 3 May 2021 | By Victoria Rees (Drug Target Review) A CRISPR-Cas9 method has been used to identify which genes play a role in repairing zebrafish spinal cord injuries.
Avocado compound targets enzyme critical to leukaemia cell growth 30 April 2021 | By Victoria Rees (Drug Target Review) The fat molecule avocatin B, found in avocados, was shown to inhibit VLCAD, an enzyme vital for leukaemia cell metabolism.
Novel nanopore platform developed to sequence DNA 30 April 2021 | By Victoria Rees (Drug Target Review) Scientists have created a new nanopore sequencing platform that can detect the presence of the nucleobases of DNA.
UK Government to fund £37 million into genomics projects 30 April 2021 | By Victoria Rees (Drug Target Review) UK Health Secretary Matt Hancock has announced £37 million of funding for genomics and data projects to support the life sciences sector.
Purified exosomal product heals ischemic wounds in pre-clinical models 29 April 2021 | By Victoria Rees (Drug Target Review) Researchers have found that ischemic wounds in pre-clinical models which were treated with a purified exosomal product were healed.
Raman spectroscopy platform developed to characterise IDPs 29 April 2021 | By Victoria Rees (Drug Target Review) Optical tweezers-coupled Raman spectroscopy has been used to reveal the structure of alpha-synuclein, an IDP linked to Parkinson's disease.
Gene changes caused by Spike protein could explain long COVID 29 April 2021 | By Victoria Rees (Drug Target Review) Scientists have shown that the SARS-CoV-2 Spike protein can initiate gene expression changes, potentially explaining long COVID symptoms.
